BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11867778)

  • 1. High-frequency Doppler US of the prostate: effect of patient position.
    Halpern EJ; Frauscher F; Forsberg F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
    Radiology; 2002 Mar; 222(3):634-9. PubMed ID: 11867778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate: high-frequency Doppler US imaging for cancer detection.
    Halpern EJ; Frauscher F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
    Radiology; 2002 Oct; 225(1):71-7. PubMed ID: 12354987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.
    Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ
    Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results.
    Ives EP; Gomella LG; Halpern EJ
    Radiology; 2005 Oct; 237(1):197-201. PubMed ID: 16183933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
    Kuligowska E; Barish MA; Fenlon HM; Blake M
    Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies.
    Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D
    Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using gray-scale and color and power Doppler sonography to detect prostatic cancer.
    Halpern EJ; Strup SE
    AJR Am J Roentgenol; 2000 Mar; 174(3):623-7. PubMed ID: 10701599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.
    Gore JL; Shariat SF; Miles BJ; Kadmon D; Jiang N; Wheeler TM; Slawin KM
    J Urol; 2001 May; 165(5):1554-9. PubMed ID: 11342916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site.
    Newman JS; Bree RL; Rubin JM
    Radiology; 1995 Apr; 195(1):86-90. PubMed ID: 7534429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy.
    Mitterberger M; Aigner F; Pinggera GM; Steiner E; Rehder P; Ulmer H; Halpern EJ; Horninger W; Frauscher F
    BJU Int; 2010 Nov; 106(9):1315-8; discussion 1318. PubMed ID: 20346032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic cancer: role of color Doppler imaging in transrectal sonography.
    Lavoipierre AM; Snow RM; Frydenberg M; Gunter D; Reisner G; Royce PL; Lavoipierre GJ
    AJR Am J Roentgenol; 1998 Jul; 171(1):205-10. PubMed ID: 9648790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography.
    Cho JY; Kim SH; Lee SE
    J Ultrasound Med; 1998 May; 17(5):283-7. PubMed ID: 9586699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of power Doppler-guided prostatic biopsy in the diagnosis of prostate cancer].
    Okihara K; Kojima M; Nakanouchi T; Okada K; Miki T
    Hinyokika Kiyo; 1999 Aug; 45(8):559-63. PubMed ID: 10500963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correlations between color Doppler using a contrast medium and the neoangiogenesis of small prostatic carcinomas].
    Lagalla R; Caruso G; Urso R; Bizzini G; Marasà L; Miceli V
    Radiol Med; 2000 Apr; 99(4):270-5. PubMed ID: 10884828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate.
    Paul R; Korzinek C; Necknig U; Niesel T; Alschibaja M; Leyh H; Hartung R
    Urology; 2004 Sep; 64(3):532-6. PubMed ID: 15351585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of power Doppler with microvessel density in assessing prostate needle biopsy.
    Wilson NM; Masoud AM; Barsoum HB; Refaat MM; Moustafa MI; Kamal TA
    Clin Radiol; 2004 Oct; 59(10):946-50. PubMed ID: 15451357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power doppler ultrasonography guided and random prostate biopsy in prostate cancer diagnosis - a comparative study.
    Sohail SK; Sarfraz R; Imran M; Khan NA; Yusuf NW
    J Pak Med Assoc; 2015 Jan; 65(1):65-8. PubMed ID: 25831678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient arteriovenous fistulae after transrectal prostate biopsy: diagnosis with color Doppler ultrasonography.
    Wachsberg RH; Rifkin MD; Needleman L; Levine CD; Simmons MZ
    J Ultrasound Med; 1996 Jan; 15(1):57-61. PubMed ID: 8667485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.